Ulcerative colitis signaling (Homo sapiens)
From WikiPathways
Description
In the upper section of the pathway, it is shown that the toll-like receptors (TLRs) recognized the components derived from microbes, such as flagellin, peptidoglycan (PGN), and lipopolysaccharide. As depicted on the left, also nucleotide-binding oligomerization domain (NOD) proteins, and antigen-presenting cells (APCs) recognized those microbial molecules. Activation of the TLR signaling pathway drives the upregulation of NF-kappa-B and its corresponding inflammation reaction. At the same time, the APC regulates the shift of naïve T-cells into effector T-cells and (Th2) and natural killer (NKT) T-cells. UC is mainly dominated by the Th2-type inflammation and the corresponding production of IL-4, IL-5, IL-13 and IL-10.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Seidelin JB, Coskun M, Kvist PH, Holm TL, Holgersen K, Nielsen OH; ''IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis.''; J Gastroenterol, 2015 PubMed Europe PMC Scholia
- Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang J, Zheng F, Wu B; ''Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis.''; Cell Death Dis, 2020 PubMed Europe PMC Scholia
- Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A; ''Innate and adaptive immunity in inflammatory bowel disease.''; Autoimmun Rev, 2014 PubMed Europe PMC Scholia
- Larabi A, Barnich N, Nguyen HTT; ''New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.''; Autophagy, 2020 PubMed Europe PMC Scholia
- Zhang SZ, Zhao XH, Zhang DC; ''Cellular and molecular immunopathogenesis of ulcerative colitis.''; Cell Mol Immunol, 2006 PubMed Europe PMC Scholia
- Ho IC, Glimcher LH; ''Transcription: tantalizing times for T cells.''; Cell, 2002 PubMed Europe PMC Scholia
- Cario E; ''Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword.''; Inflamm Bowel Dis, 2008 PubMed Europe PMC Scholia
- Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K; ''Immune response and inflammatory pathway of ulcerative colitis.''; J Basic Clin Physiol Pharmacol, 2018 PubMed Europe PMC Scholia
- ''''; , PubMed Europe PMC Scholia
- Negi S, Saini S, Tandel N, Sahu K, Mishra RPN, Tyagi RK; ''Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice.''; Cells, 2021 PubMed Europe PMC Scholia
- Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ; ''Ulcerative colitis.''; Lancet, 2012 PubMed Europe PMC Scholia
- Rosen MJ, Chaturvedi R, Washington MK, Kuhnhein LA, Moore PD, Coggeshall SS, McDonough EM, Weitkamp JH, Singh AB, Coburn LA, Williams CS, Yan F, Van Kaer L, Peebles RS Jr, Wilson KT; ''STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.''; J Immunol, 2013 PubMed Europe PMC Scholia
- Kmieć Z, Cyman M, Ślebioda TJ; ''Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease.''; Adv Med Sci, 2017 PubMed Europe PMC Scholia
- Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N; ''Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.''; World J Gastroenterol, 2016 PubMed Europe PMC Scholia
- Ben-Sasson SZ, Le Gros G, Conrad DH, Finkelman FD, Paul WE; ''IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production.''; J Immunol, 1990 PubMed Europe PMC Scholia
- Singh SP, Chand HS, Banerjee S, Agarwal H, Raizada V, Roy S, Sopori M; ''Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.''; Dig Dis Sci, 2020 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Annotated Interactions
No annotated interactions